V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004255 | 10002693 | 1.77 | 88.8 | Curative (C) | 2014-11-11 | 2014-12-03 | CAPECITABINE + GEMCITABINE | N | N | 10515485 | BORTEZOMIB |
| 10004256 | 10002693 | 1.79 | 98.7 | Curative (C) | 2017-03-15 | 2017-03-25 | Gemcitabine + Capecitabine | 02 | N | 10515485 | CISPLATIN + ETOPOSIDE |
| 10004257 | 10002694 | 1.79 | 66.3 | Curative (C) | 2016-08-29 | 2016-08-29 | FEC 100 + DOCETAXEL | 2 | N | 10515532 | FEC + DOCETAXEL |
| 10004258 | 10002694 | null | 68.1 | Palliative (P) | 2018-04-26 | 2018-04-26 | ABVD | N | null | 10515532 | EC |
| 10004259 | 10002694 | null | 132.6 | Palliative (P) | 2016-04-17 | 2016-04-17 | Irinotecan + Modified De Gramont | N | null | 10515532 | IRINOTECAN + MDG |
| 10004260 | 10002695 | 1.7 | 70.4 | Not known (9) | 2014-04-15 | 2014-04-24 | FEC + DOCETAXEL | N | N | 10515671 | FEC + DOCETAXEL |
| 10004261 | 10002696 | 1.7 | 60 | Adjuvant (A) | 2018-07-14 | 2018-07-17 | CHOP - 21 days | 02 | N | 10515683 | PACLITAXEL |
| 10004262 | 10002697 | 1.56 | 86 | Disease modification (D) | 2017-01-08 | 2017-01-09 | CTD | 02 | N | 10515709 | AZACITIDINE |
| 10004263 | 10002698 | 1.65 | 71.7 | Palliative (P) | 2016-04-21 | 2016-04-21 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 10515745 | BORTEZOMIB |
| 10004264 | 10002698 | 1.82 | 50 | Neo-adjuvant (N) | 2018-03-26 | 2018-03-27 | FEC + DOCETAXEL | 02 | N | 10515745 | FEC + DOCETAXEL |
| 10004265 | 10002699 | null | null | Palliative (P) | 2015-10-03 | 2015-10-21 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10515858 | CHOP |
| 10004266 | 10002699 | 1.62 | 0 | Disease modification (D) | 2019-01-22 | 2019-01-22 | FLUOROURACIL + MITOMYCIN + RT | 2 | N | 10515858 | BCG |
| 10004267 | 10002700 | 1.75 | null | Palliative (P) | 2017-12-19 | 2018-01-16 | Irinotecan + Modified De Gramont | N | null | 10515916 | IRINOTECAN + MDG |
| 10004268 | 10002701 | null | null | Curative (C) | 2016-08-14 | 2016-08-14 | Cisplatin + Radiotherapy | null | null | 10515931 | CISPLATIN + RT |
| 10004269 | 10002702 | 1.72 | 99.8 | Curative (C) | 2017-01-16 | 2017-02-03 | EC | N | N | 10516043 | BCG |
| 10004270 | 10006614 | 1.57 | 62.2 | Adjuvant (A) | 2014-08-13 | 2014-08-19 | BCG Intravesical | 02 | N | 10516160 | PACLITAXEL |
| 10004271 | 10006614 | 1.65 | 65.6 | Palliative (P) | 2015-11-03 | 2015-11-03 | CTD | 02 | N | 10516160 | IMATINIB |
| 10004272 | 10002703 | 1.57 | 46.3 | Curative (C) | 2017-04-09 | 2017-05-05 | CISPLATIN + RT | N | Y | 10516281 | CISPLATIN + RT |
| 10004273 | 10002704 | 1.62 | 60.9 | Disease modification (D) | 2017-11-01 | 2017-11-10 | Paclitaxel 7 day | 02 | null | 10516284 | CAPECITABINE + GEMCITABINE |
| 10004274 | 10002705 | 1.69 | 78.9 | Neo-adjuvant (N) | 2018-01-16 | 2018-02-07 | CAPECITABINE + RT | N | N | 10516321 | CAPECITABINE + RT |
| 10004275 | 10002706 | 1.66 | 69.4 | Palliative (P) | 2016-04-24 | 2016-05-15 | Cisplatin + Etoposide (3 day) | N | N | 10516384 | ABIRATERONE |
| 10004276 | 10002707 | 1.38 | null | Disease modification (D) | 2018-11-12 | 2018-11-13 | BCG Intravesical | N | N | 10516454 | CISPLATIN + ETOPOSIDE |
| 10004277 | 10002708 | 1.63 | 61.5 | Adjuvant (A) | 2017-01-16 | 2017-01-16 | ABVD | 2 | N | 10516481 | CISPLATIN + ETOPOSIDE |
| 10004278 | 10002709 | 1.6 | 57.7 | Palliative (P) | 2014-10-25 | 2014-10-26 | Irinotecan + Modified De Gramont | 02 | N | 10516562 | IRINOTECAN + MDG |
| 10004279 | 10002710 | 1.75 | null | Palliative (P) | 2018-01-23 | 2018-01-26 | Temozolomide + RT | 02 | N | 10516710 | PACLITAXEL |
| 10004280 | 10006615 | 1.69 | 91.8 | Not known (9) | 2017-02-24 | 2017-03-17 | Fluorouracil + Folinic Acid Weekly | N | N | 10516734 | FLUOROURACIL |
| 10004281 | 10006615 | 1.78 | 79.6 | Palliative (P) | 2018-03-20 | 2018-03-28 | Chlorambucil | 02 | N | 10516734 | CTD |
| 10004282 | 10006615 | 1.74 | 71.5 | Curative (C) | 2018-05-21 | 2018-06-01 | FEC + DOCETAXEL | 02 | N | 10516734 | FEC + DOCETAXEL |
| 10004283 | 10006615 | 1.67 | 75.4 | Disease modification (D) | null | 2018-11-14 | FLUOROURACIL + MITOMYCIN + RT | N | Y | 10516734 | AZACITIDINE |
| 10004284 | 10006615 | null | 102 | Curative (C) | 2015-02-08 | 2015-02-09 | Azacitidine | N | N | 10516734 | CTD |
| 10004285 | 10006615 | 1.58 | 56.8 | Curative (C) | 2014-04-17 | 2014-05-01 | CISPLATIN + RT | 02 | Y | 10516734 | CISPLATIN + RT |
| 10004286 | 10006615 | 1.68 | 80.9 | Adjuvant (A) | 2016-11-30 | 2016-12-01 | Azacitidine | N | N | 10516734 | ABVD |
| 10004287 | 10002711 | null | 98.7 | Palliative (P) | 2015-03-25 | 2015-03-27 | MaxiCHOP (Cycle 1) | N | N | 10516976 | TEMOZOLOMIDE + RT |
| 10004288 | 10002712 | null | 88.7 | Curative (C) | 2017-09-27 | 2017-10-01 | Capecitabine + Cisplatin | 02 | N | 10517051 | PACLITAXEL |
| 10004289 | 10002713 | 1.62 | 123 | Palliative (P) | 2018-05-20 | 2018-05-27 | Irinotecan + Modified De Gramont | N | N | 10517053 | IRINOTECAN + MDG |
| 10004290 | 10002714 | 1.75 | 81 | Palliative (P) | 2018-08-27 | 2018-09-02 | Temozolomide + RT | 2 | N | 10517177 | BCG |
| 10004291 | 10002715 | 0 | 86.8 | Adjuvant (A) | 2014-06-11 | 2014-06-11 | BCG Intravesical | 02 | N | 10517209 | IMATINIB |
| 10004292 | 10002716 | 1.9 | 70 | Adjuvant (A) | 2017-02-01 | 2017-02-04 | Paclitaxel 7 day | 2 | N | 10517263 | CHLORAMBUCIL |
| 10004293 | 10002717 | 1.58 | 63.8 | Palliative (P) | 2017-04-23 | 2017-04-23 | EC | N | N | 10517303 | CHLORAMBUCIL |
| 10004294 | 10002717 | null | 70.6 | Curative (C) | 2018-06-30 | 2018-07-05 | CTD | 02 | N | 10517303 | EC |
| 10004295 | 10002717 | 1.71 | null | Neo-adjuvant (N) | 2018-09-30 | 2018-10-01 | CAPECITABINE + RT | N | null | 10517303 | CAPECITABINE + RT |
| 10004296 | 10002717 | 1.8 | 77.3 | Curative (C) | 2016-07-09 | 2016-07-13 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 2 | N | 10517303 | CHLORAMBUCIL |
| 10004297 | 10002717 | null | null | Palliative (P) | 2016-06-23 | 2016-07-08 | Irinotecan + Modified De Gramont | N | Y | 10517303 | IRINOTECAN + MDG |
| 10004298 | 10002717 | 1.62 | 76.1 | Curative (C) | 2018-10-19 | 2018-10-25 | IMATINIB | 02 | N | 10517303 | CISPLATIN + ETOPOSIDE |
| 10004299 | 10002717 | 1.77 | 88 | Curative (C) | 2015-11-30 | 2015-12-04 | Bortezomib +/- Dexamethasone | 02 | N | 10517303 | CISPLATIN + ETOPOSIDE |
| 10004300 | 10002718 | 1.73 | 95.2 | Curative (C) | 2016-10-29 | 2016-11-01 | Temozolomide + RT | N | null | 10517609 | ABVD |
| 10004301 | 10002719 | 1.77 | null | Adjuvant (A) | null | 2017-10-13 | Cisplatin + Etoposide (3 day) | N | N | 10517615 | ABIRATERONE |
| 10004302 | 10002719 | 1.72 | 67.6 | Palliative (P) | 2018-11-22 | 2018-11-22 | CHOP | N | null | 10517615 | TEMOZOLOMIDE + RT |
| 10004303 | 10002720 | 1.7 | 79.9 | Curative (C) | 2016-07-05 | 2016-07-16 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10517635 | CISPLATIN + ETOPOSIDE |
| 10004304 | 10002721 | 1.84 | null | Palliative (P) | 2016-04-03 | 2016-05-21 | Temozolomide + RT | 02 | N | 10517681 | TEMOZOLOMIDE + RT |